Multiple myeloma

Multiple myeloma

Understanding Multiple Myeloma

Multiple myeloma, a form of blood cancer which originates in plasma cells, a particular type of white blood cell that is responsible in the production of antibodies that protect the body from infections. In this case abnormal plasma cells multiply rapidly within bone marrow impairing normal blood cell development and release harmful proteins that harm tissues and organs.

The disease may be asymptomatic for a prolonged period of time and might not require immediate treatment in the initial inactive or even active stages. But, when it is active, it requires medical intervention to treat signs, avoid complications and to stop disease progression.

Common Signs and Symptoms

While the early stages of multiple myeloma might not be symptomatic however, the following signs may be seen as the disease progresses:

  • The persistent bone pain is usually in the ribs and spine

  • The chronic fatigue of the body and weakening

  • Infections that are frequent

  • Trouble concentrating or confusion

  • Unintentional weight loss

  • Constipation and nausea

  • Numbness or weakness in the legs

  • Dehydration and excessive thirst

  • The recurrence of fever is not a definitive root

How Multiple Myeloma Develops

The disorder usually starts with one abnormal plasma cell found in the bone marrow. The mutated cell reproduces quickly and is able to evade normal cell death by accumulating, and invading healthy blood-forming cells.

The cancerous cells in the plasma produce an abnormal protein called M proteins which lacks beneficial immune function, and can result in complications like kidney disease, bone destruction or anemia. As time passes the abnormal protein and the growing number of myeloma cells can compromise the immune system and production of red blood cells, and bone structure.

What Increases the Risk?

The exact reason for multiple myeloma is undetermined, a variety of factors are identified as increasing the chance of getting the condition:

  • Age Most diagnoses are made after the age of 60.

  • Gender Males are more often affected than females.

  • Etymology people of African descendance have a higher rate of

  • Family background A close family member who has multiple myeloma can increase the chance of being diagnosed.

  • MGU (Monoclonal Gammopathy of Unknown Relevance): This benign precursor condition can develop into multiple myeloma in the future.

Potential Complications

If left untreated or in advanced stages the disease can cause:

  • Bones with weak bones Fractures or bone thinning. chronic discomfort

  • More infections due to a weak immune system function

  • Kidney dysfunction caused by the buildup of M proteins in bloodstreams

  • Anemia Red blood cell count due to overcrowding bone Marrow

Diagnosing Multiple Myeloma

A thorough medical exam is necessary to determine the presence of multiple myeloma. Steps to diagnose comprise:

  • Tests for blood to look for abnormalities in blood cells and proteins. counts

  • Tests of Urine for lighter chains as well as M protein

  • Bone Marrow Biopsies to determine the activity of plasma cells

  • Imaging X-rays, MRI or PET scans can show bone injury

Multiple Myeloma Treatment Options

The treatment is based on how severe the illness is and the general condition of the person. The most common treatment options are:

  • “Observation” (“watchful patiently waiting”): For patients suffering from smoldering or inactive disease

  • Chemotherapy to destroy myeloma cells that are rapidly growing

  • Therapeutically targeted drugs specifically target cancerous plasma cells.

  • Immunotherapy Utilizes your body’s immunity system to combat the illness

  • Corticosteroids To decrease inflammation and kill cancerous cells

  • Stem transplantation of cells replaces diseased marrow with healthy cells

  • Bone-strengthening substances such as bisphosphonates to stop fractures

  • Helpful care This includes water, antibiotics, and the management of pain

Live with Multiple Myeloma

Although it is currently incurable, many patients with multiple myeloma lead longer, healthier lives because of advances in early diagnosis and customized treatment. Regularly monitored and customized care plans are crucial to managing the disease as it progresses.

Best Haematologist in India

About the Doctor

Dr. Padmaja Lokireddy is a highly respected Hemato Oncologist, Bone Marrow & Stem Cell Transplant Surgeon with years of experience in the field. She earned her postgraduate degree in internal medicine from the prestigious Manipal Academy of Higher Education and continued her studies and worked in the UK for about 13 years.

0
Years of experience


0
Patients Treated


0%
Success rate


AWARDS

India Brand Icon Award – 2020

India Brand Icon Award for Healthcare Excellence (Hemato-Oncology & Bone Marrow Transplant) By Time Cyber Media.

Meritorious Award

Meritorious Award in the field of Hematology and Transplant by International Biographic centre, Cambridge 2016.

International Biographic Dictionary, Cambridge

Included in International Biographic Dictionary, Cambridge and recognised in the top 100 physicians for 2016.

India Brand Icon Award – 2020

India Brand Icon Award for Healthcare Excellence (Hemato-Oncology & Bone Marrow Transplant) By Time Cyber Media.

Meritorious Award

Meritorious Award in the field of Hematology and Transplant by International Biographic centre, Cambridge 2016.

International Biographic Dictionary, Cambridge

Included in International Biographic Dictionary, Cambridge and recognised in the top 100 physicians for 2016.

Insights & Interviews: Bone Marrow Transplant Journey

Patient Testimonials & Success Stories